RISK WARNING: Your capital is at risk. The risks include: the lack of liquidity in this market in terms of being able to realise investments and the loss of the value of investment. When you invest any loss in value will not be covered by the Financial Services Compensation Scheme.
Please read FULL risk warning.
Bioinduction aims to make neurostimulation as mainstream as cardiac pacemakers are today: Stimulating the nervous system to replace drugs.
CAUTION: This project has not been approved as a financial promotion. No investment decisions about the project should be made on the basis of information provided on this platform.
This company has not shared it's twitter feed.
Our mission is:
- To disrupt Deep Brain Stimulation (DBS) markets through the introduction of the Picostim technology, a neurostimulator 60% smaller than competitors and capable of implantation in around half the time.
- To leverage efficiency savings engendered by such a device by expanding into indications of scale such as drug resistant hypertension, stroke and vascular dementia, currently with high unmet need and targeted near-exclusively by Pharma.